Contact Investor Relations

9595 Wilshire Boulevard, Ste. 900
Beverly Hills, CA 90212

Investor Relations and Corporate Communications

Request Investor Information

  • This field is for validation purposes and should be left unchanged.


July 18th, 2017

Rich Pharmaceuticals Announces Collaboration Agreement To Support The Development of Treatments For Parkinson’s Disease: Company Will Receive Cash and Stock and Plans to Pay One Third of the Shares Received in a Dividend to Shareholders
View Release

June 21st, 2017

Rich Pharmaceuticals Announces Principal Doctor for Clinical Trials
View Release

June 8th, 2017

Rich Pharmaceuticals Announces Institutional Review Board Submission
View Release

» View All News

Stock Price